The Monday US trading session, on the day before Christmas Eve, brings a another downward impulse across the US equities after the biggest on record US 'Triple Witching' day on December 20, 2024. The US500 struggled to increase above the resistance zone at 6000 points, and DJIA (US30) is losing more than 0.8% today, making investors more stressed before the tomorrow's Christmas Eve.
- Wall Street opened today's session in a quite positive sentiments, especially around tech-sector with US100 gaining almost 0.5%. However, after US CB consumer sentiments, Wall Street loses, with US100 down 0.2% and US30 sliding as much as 0.8%
- Shares of semiconductor companies dominate bull activity on Wall Street today; Broadcom (AVGO.US) and AMD (AMD.US) shares rise more than 4%. Shares of Arm Holdings (ARM.US) lose nearly 5% as company lost in the court agains Broadcom (AVGO.US)
- Shares of quantum computing-related company Rigetti Computing and space equipment maker Intuitive Machines gain nearly 15%.Â
US Macro
US macro readings (Consumer Confidence) and new home sales came in unexpectedly well below expectations. Investors fear that the Fed will slow rate cuts in 2025 (pressured also by tariffs), even despite (unexpectedly)Â slowing US economic activity.
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appSource: XTB Research, Bloomberg Finance L.P.
US CB Consumer Confidence: 104.7 vs 113.2 exp. and 111.7 previously
- US New Home Sales: 0.664M (Forecast 0.669M, Previous 0.610M)
-
US November median home sale price $402,600, down 6.3% since November 2023 ($429,600)
-
US New Home Sales (MoM): 5.9% vs 9.7% exp. and -17.3% previously
The recent upward momentum continues with shares of U.S.-based Eli Lilly, whose obesity drugs are trading higher than rival Danish drugmaker Novo Nordisk; the company's shares are trading up 4% today after a 20% sell-off last Friday. Outside of technology, we see declines dominating today. Palantir loses almost 4% today. We can see that valuation of almost all US companies is dropping today. Source: xStation5
US100 and US30 (M15 interval)
Despite the rise in chip companies, the other stocks in the Nasdaq 100 index are limiting the unwinding of the overall benchmark today. We can consider that further upward momentum is still not guaranteed, and the selling volume also remains elevated after the roll-off.
Source: xStation5
Source: xStation5
News from companies
- Applied Therapeutics (APLT.US) loses 4% after analysts at William Blair withdrew a positive rating on the stock due to increased uncertainty about the efficacy of the Govorestat drug and limited cash.
- Qualcomm (QCOM.US) is gaining after the company won a lawsuit against a claim by Arm Holdings Plc that it infringed on a chip technology license that the world's largest cell phone processor maker acquired when it bought the startup in 2021. Arm (ARM.US) shares lose nearly 5% today
- Rigetti Computing and other quantum computing-related stocks including IONQ (IONQ.US) are rising thanks to optimism about the long-term utility of Alphabet's Willow chips
Xerox (XRX.US) gains nearly 10% after agreeing to buy laser printer maker Lexmark International Inc. from a consortium of Asian investors; the deal is valued at about $1.5 billion. Lexmark was sold to Chinese investors by IBM, in 2016 for $3.6 billion. Xerox's current capitalization is about $1 billion. The company still faces competition from Canon and HP. The largely printer-based business continues to make losses for Xerox. The company remains active in 170 markets and serves more than 200,000 customers. The deal will be partially financed with the company's cash. The company has cut its annual dividend by 50% to $0.5 per share to finance the acquisition and reduce debt. Some investors expect Lexmkar could bring the company more growth in Asian markets.
Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.